These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 9387908)
1. Triple combination antimicrobial regimen in the treatment of infections of neutropenic cancer patients. Casali A; Santini S; Della Giulia M; Di Lauro L; Vici P; Gionfra T; Sega FM J Exp Clin Cancer Res; 1997 Sep; 16(3):321-4. PubMed ID: 9387908 [TBL] [Abstract][Full Text] [Related]
2. A comparison of aztreonam plus vancomycin and imipenem plus vancomycin as initial therapy for febrile neutropenic cancer patients. Raad II; Whimbey EE; Rolston KV; Abi-Said D; Hachem RY; Pandya RG; Ghaddar HM; Karl CL; Bodey GP Cancer; 1996 Apr; 77(7):1386-94. PubMed ID: 8608520 [TBL] [Abstract][Full Text] [Related]
3. [Value of the combination of piperacillin and pefloxacin possibly followed by vancomycin in the treatment of febrile neutropenia in nephrotoxic chemotherapy]. Kattan J; Droz JP; Culine S; Ribrag V; Boutan-Laroze A; Andremont A Bull Cancer; 1992; 79(7):705-12. PubMed ID: 1467596 [TBL] [Abstract][Full Text] [Related]
4. [Management of 315neutropenic febrile episodes in a cancer center]. Dutronc H; Billhot M; Dupon M; Eghbali H; Donamaria C; Dauchy FA; Reiffers J Med Mal Infect; 2009 Jun; 39(6):388-93. PubMed ID: 19062208 [TBL] [Abstract][Full Text] [Related]
5. Non-nephrotoxic empiric antimicrobial therapy in febrile neutropenic cancer patients. Kattan J; Droz JP; Ribrag V; Azab M; Boutan-Laroze A; Andremont A Eur J Cancer; 1992; 28A(4-5):867-70. PubMed ID: 1524911 [TBL] [Abstract][Full Text] [Related]
6. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors. Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540 [TBL] [Abstract][Full Text] [Related]
7. Clinical and economic evaluation of subsequent infection following intravenous ciprofloxacin or imipenem therapy in hospitalized patients with severe pneumonia. Caldwell JW; Singh S; Johnson RH J Antimicrob Chemother; 1999 Mar; 43 Suppl A():129-34. PubMed ID: 10225583 [TBL] [Abstract][Full Text] [Related]
8. [Value of mono-antibiotic therapy using piperacillin associated with sulbactam and possibly followed by vancomycin in febrile neutropenia in solid tumors]. Abs L; Kattan J; Culine S; Bekradda M; Farhat F; Droz JP Bull Cancer; 1994 Oct; 81(10):871-6. PubMed ID: 7734770 [TBL] [Abstract][Full Text] [Related]
9. Immediate vs. delayed imipenem treatment in cancer patients with profound neutropenia induced by high-dose chemotherapy: results of a randomized study. García-Sáenz JA; Martín M; Casado A; Pérez-Segura P; Manrique I; Flores L; Macias JA; Cámara JC; Perezagua C; Díaz-Rubio E Rev Esp Quimioter; 2002 Sep; 15(3):257-63. PubMed ID: 12582429 [TBL] [Abstract][Full Text] [Related]
10. Treatment of febrile neutropenic patients with cancer who require hospitalization: a prospective randomized study comparing imipenem and cefepime. Raad II; Escalante C; Hachem RY; Hanna HA; Husni R; Afif C; Boktour MR; Whimbey EE; Kontoyiannis D; Jacobson K; Kantarjian H; Levett LM; Rolston KV Cancer; 2003 Sep; 98(5):1039-47. PubMed ID: 12942573 [TBL] [Abstract][Full Text] [Related]
11. Clinical guidelines for the management of neutropenic patients with unexplained fever in Japan: validation by the Japan Febrile Neutropenia Study Group. Tamura K Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S123-7; discussion S133-40. PubMed ID: 16249072 [TBL] [Abstract][Full Text] [Related]
12. Comparison of norfloxacin and pefloxacin in the prophylaxis of bacterial infection in neutropenic cancer patients. D'Antonio D; Iacone A; Fioritoni G; Betti S; Dell'Isola M; Quaglietta AM; Accorsi P; Pantalone V; Recchia A; Piergallini A Drugs Exp Clin Res; 1992; 18(4):141-6. PubMed ID: 1451644 [TBL] [Abstract][Full Text] [Related]
13. Management of the febrile neutropenic patient. Picazo JJ; Int J Antimicrob Agents; 2005 Dec; 26 Suppl 2():S120-2; discussion S133-40. PubMed ID: 16243492 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of linezolid compared with vancomycin in a randomized, double-blind study of febrile neutropenic patients with cancer. Jaksic B; Martinelli G; Perez-Oteyza J; Hartman CS; Leonard LB; Tack KJ Clin Infect Dis; 2006 Mar; 42(5):597-607. PubMed ID: 16447103 [TBL] [Abstract][Full Text] [Related]
15. Management of fever in neutropenic patients with different risks of complications. Klastersky J Clin Infect Dis; 2004 Jul; 39 Suppl 1():S32-7. PubMed ID: 15250018 [TBL] [Abstract][Full Text] [Related]
18. [Febrile neutropenia: empiric antibiotic therapy from 1975 to 1997]. Klastersky J Rev Med Brux; 1997 Oct; 18(5):323-7. PubMed ID: 9441328 [TBL] [Abstract][Full Text] [Related]
19. How should imipenem-cilastatin be used in the treatment of fever and infection in neutropenic cancer patients? Raad II; Abi-Said D; Rolston KV; Karl CL; Bodey GP Cancer; 1998 Jun; 82(12):2449-58. PubMed ID: 9635539 [TBL] [Abstract][Full Text] [Related]
20. Imipenem versus targeted therapy in cancer patients. Aoun M; Crokaert F; Paesmans M; Autier P; Klastersky J Int J Antimicrob Agents; 1998 Nov; 10(4):263-70. PubMed ID: 9916899 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]